Skip to main content
Preclinical Respiration and Inhalation Lab Equipment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Preclinical Respiration and Inhalation Lab Equipment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Published: Jan 2024 158 Pages SKU: IRTNTR44890

Market Overview at a Glance

$4.16 B
Market Opportunity
4.29%
CAGR
3.65
YoY growth 2023-2024(%)

Preclinical Respiration and Inhalation Lab Equipment Market 2024-2028

The preclinical respiration and inhalation lab equipment market size is forecast to increase by USD 4.16 million, at a CAGR of 4.29% between 2023 and 2028

There has been an increase in research on respiratory diseases across the globe. In addition, the market is witnessing an increase in respiratory research, which can be attributed to the growing investments in R&D activities focused on respiratory diseases. Furthermore, substantial advances have been made toward understanding the basic mechanisms of pulmonary diseases as well as optimizing their clinical management, as respiratory diseases are a major public health concern globally. Hence, such factors are positively impacting the market.

Technavio has segmented the market into Type, End-user, and Geography

  • The type segment is classified into respiration equipment and inhalation equipment
  • The end-user segment is classified into CROs and academic institutes and pharma and biotech companies
  • The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Preclinical Respiration and Inhalation Lab Equipment Market During the Forecast Period?

Preclinical Respiration and Inhalation Lab Equipment Market Size

To learn more about this report, Download Report Sample

Preclinical Respiration and Inhalation Lab Equipment Market Segmentation by Type, End-user, and Geography Analysis

Type Analysis

Respiration equipment

The respiration equipment segment is estimated to witness significant growth during the forecast period. Respiration equipment is referred to as a collection of instruments and gadgets used to measure, track, and examine respiratory parameters in living things. In addition, this apparatus is frequently used to evaluate different facets of respiratory function in scientific, medical, and preclinical research contexts.

Preclinical Respiration and Inhalation Lab Equipment Market Size

Get a glance at the market contribution of various segments Download PDF Sample

The respiration equipment segment was the largest segment and was valued at USD 12.93 billion in 2018. Moreover, devices for measuring tidal volume, respiratory rate, minute ventilation, and gas exchange are examples of equipment used in respiration measurements. In addition, it might also entail using specialized equipment to perform experiments on respiratory physiology and pathology, evaluate lung function, and investigate the effects of substances inhaled. Furthermore, research on respiratory health in general, drug development, inhalation toxicology studies, and respiratory diseases all greatly benefit from the equipment. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

End-user Analysis

CROs and academic institutes

Preclinical respiration and inhalation lab equipment are extensively adopted for respiratory research as well as drug discovery. In addition, several pharmaceutical companies, big and small, have been outsourcing work to contract research organizations (CROs), while academic institutes that lack the infrastructure or equipment for performing certain tasks, also depend on outsourcing. Moreover, several academic institutes also prefer to perform all the preclinical respiratory research-related tasks on their premises for better monitoring and control over experiments. Furthermore, biopharmaceutical companies are increasingly dependent on CROs for services in the areas of preclinical and clinical research as well as drug discovery due to the high pressure on them to improve the productivity of their R&D activities. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Pharma and biotech companies

Some of the major pharmaceutical and biotechnology companies have developed the infrastructure needed to conduct experiments/research related to drug discovery as well as preclinical and clinical studies, due to the lack of a robust structural framework among CROs, which are not equipped enough to meet the rising demand from them. In addition, many major pharmaceutical companies that work on medicines to treat respiratory conditions acquire small-scale CROs to perform in-house respiratory-related research activities. Moreover, factors such as adverse working conditions and the increasing number of underpaid staff in the facilities of numerous CROs are facilitating pharmaceutical and biotechnology companies to opt to conduct respiratory-related research activities in their premises. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

Preclinical Respiration and Inhalation Lab Equipment Market Share by Geography

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 48% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The large market share of North America in 2023 in the global preclinical respiration and inhalation lab equipment market is fuelled by the rising spending on R&D, the increasing focus on respiratory research, and the presence of key market players with their headquarters in the region. In addition, in North America, a significant number of people suffer from respiratory disorders, such as asthma, COPD, lung cancer, pneumonia, and chronic sinusitis.

Moreover, most of these respiratory diseases are primarily caused by genetic mutations and medical history, dust, air pollution, tobacco smoke, and occupational chemicals. Therefore., this has led to a substantial demand for respiratory research, which, in turn, has resulted in a rapid rise in the R&D expenditure on respiratory research to study pulmonary function. Hence, such factors are driving the market growth in North America during the forecast period.

Buy Full Report Now

Key Preclinical Respiration and Inhalation Lab Equipment Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 17 market companies, including:

4DMedical Ltd: The company offers preclinical respiration and inhalation lab equipment namely XV Technology. Additionally, XY technology can be used for imaging lung function by using hospital imaging systems and X ray images from different angles.

  • ADInstruments Pty Ltd.
  • Bruker Corp.
  • CH Technologies USA Inc.
  • Columbus Instruments LLC
  • CWE
  • emka TECHNOLOGIES
  • EMMS
  • Harvard Bioscience Inc.
  • IN TOX PRODUCTS LLC
  • Kent Scientific Corp.
  • Koninklijke Philips N.V.
  • Lab Products Inc.
  • NuAire Inc.
  • TSE Systems GmbH
  • Vivotecnia
  • RWD Life Science Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Preclinical Respiration and Inhalation Lab Equipment Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Preclinical Respiration and Inhalation Lab Equipment Market Drivers

One of the key factors driving the preclinical respiration and inhalation lab equipment market growth is the growing prevalence of respiratory disorders. Chronic respiratory diseases, including chronic obstructive respiratory disease (COPD) and asthma, affect the airways and lungs. In addition, they are primarily caused by dust, air pollution, tobacco smoke, and exposure to occupational chemicals.  Furthermore, patients with chronic respiratory diseases, such as COPD and asthma, are advised to undergo continuous monitoring to identify the associated risks.

Moreover, the prevalence of chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, is increasing across the globe. In addition, the prevalence of respiratory diseases, such as asthma and COPD, is specifically high among geriatric people as the strength of the respiratory muscles declines with age. Furthermore, the risks associated with respiratory disorders, such as diabetes, smoking, and obesity, are also on the rise. Hence, such factors are driving the market growth during the forecast period.

Significant Preclinical Respiration and Inhalation Lab Equipment Market Trends

A key factor shaping the preclinical respiration and inhalation lab equipment market growth is the growing popularity of minimally invasive techniques in respiratory research. With the increasing prevalence of respiratory disorders, including asthma, COPD, and infectious respiratory diseases, more research on lung function is becoming essential for drug discovery as well as other purposes. In addition, pulmonary function is a relevant endpoint in both pharmacological and toxicological studies on respiratory diseases.

Moreover, the assessment of drug effects on vital organ systems, such as the respiratory system, requires the use of non-invasive or minimally invasive techniques in conscious rodents, where the use of anesthesia is not necessary. Therefore, minimally invasive techniques are gaining prominence in respiratory research. Hence, such factors are driving the market growth during the forecast period.

Major Preclinical Respiration and Inhalation Lab Equipment Market Challenges

Limitations of animal studies are one of the key challenges hindering the preclinical respiration and inhalation lab equipment market growth. Although animal specimens are often beneficial and are increasingly utilized in respiratory research, there are various limitations to animal studies. In addition,  one of the major limitations that scientists face during respiratory research is the inability to replicate animal studies in human trials.

Moreover, this can be attributed to the poor design of the procedures in experiments, the choice of incorrect approaches while conducting the procedures in the lab environment, or the inaccurate analysis of the measurements. Furthermore, animal specimens, such as mice, offer promising potential for assessing the effects of drugs, mediators, and infectious agents on the human lungs and their function. Hence, such factors are negatively impacting the market which in turn hinders the market growth during the forecast period.

Buy Now Full Report

Key Preclinical Respiration and Inhalation Lab Equipment Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Preclinical Respiration and Inhalation Lab Equipment Market Share by Geography

Global Preclinical Respiration and Inhalation Lab Equipment Market Customer Landscape

Segment Overview

The preclinical respiration and inhalation lab equipment market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028. 

  • Type Outlook
    • Respiration equipment
    • Inhalation equipment
  • End-user Outlook
    • CROs and academic institutes
    • Pharma and biotech companies
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Preclinical Respiration and Inhalation Lab Equipment Market Scope

Report Coverage

Details

Page number

158

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 4.29%

Market Growth 2024-2028

USD 4.16 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

3.65

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 48%

Key countries

US, Germany, France, UK, and China

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

4DMedical Ltd, ADInstruments Pty Ltd., Bruker Corp., CH Technologies USA Inc., Columbus Instruments LLC, CWE, emka TECHNOLOGIES, EMMS, Harvard Bioscience Inc., IN TOX PRODUCTS LLC, Kent Scientific Corp., Koninklijke Philips N.V., Lab Products Inc., NuAire Inc., TSE Systems GmbH, Vivotecnia, and RWD Life Science Co. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Preclinical Respiration and Inhalation Lab Equipment Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the preclinical respiration and inhalation lab equipment market  between 2023 and 2028
  • Precise estimation of the preclinical respiration and inhalation lab equipment market size and its contribution to the market in focus on the parent market
  • Detailed market research and growth of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate market forecast about upcoming market growth and trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough market growth and forecasting of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report of factors that will challenge the growth of preclinical respiration and inhalation lab equipment market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Preclinical Respiration and Inhalation Lab Equipment market growth will increase by $ 4.16 bn during 2024-2028.

The Preclinical Respiration and Inhalation Lab Equipment market is expected to grow at a CAGR of 4.29% during 2024-2028.

Preclinical Respiration and Inhalation Lab Equipment market is segmented by Type( Respiration equipment, Inhalation equipment) End-user( CROs and academic institutes, Pharma and biotech companies, Pharma, biotech companies)

4DMedical Ltd, ADInstruments Pty Ltd., Bruker Corp., CH Technologies USA Inc., Columbus Instruments LLC, CWE, emka TECHNOLOGIES, EMMS, Harvard Bioscience Inc., IN TOX PRODUCTS LLC, Kent Scientific Corp., Koninklijke Philips N.V., Lab Products Inc., NuAire Inc., TSE Systems GmbH, Vivotecnia, RWD Life Science Co. Ltd. are a few of the key vendors in the Preclinical Respiration and Inhalation Lab Equipment market.

North America will register the highest growth rate of 48% among the other regions. Therefore, the Preclinical Respiration and Inhalation Lab Equipment market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Germany, France, UK, China

  • Rise in research on respiratory diseasesThe market is witnessing a rise in respiratory research is the driving factor this market.
  • which can be attributed to the increasing investments in R and D activities focused on respiratory diseases. Substantial advances have been made toward understanding the basic mechanisms of pulmonary diseases as well as optimizing their clinical management is the driving factor this market.
  • as respiratory diseases are a major public health concern globally. However is the driving factor this market.
  • the need for better knowledge of the approaches for disease prediction prior to the manifestation of symptoms is increasing rapidly. Additionally is the driving factor this market.
  • the rising demand for adopting novel and personalized therapeutic methods is the driving factor this market.
  • as well as the enhanced ability to define diseases and their subclassifications is the driving factor this market.
  • are fueling respiratory research. Hence is the driving factor this market.
  • many governmental bodies is the driving factor this market.
  • as well as independent organizations is the driving factor this market.
  • provide funding and support for research worldwide. For instance is the driving factor this market.
  • the Framework Program for Research and Innovation (2014 - 2020) is the driving factor this market.
  • Horizon 2020 is the driving factor this market.
  • provides several opportunities to address the need for unmet innovations as well as research in the area of respiratory diseases. The European Commission launched the program with a focus on interventional research on the prevention and treatment of lung diseases among vulnerable populations in both high-income countries and low- and middle-income countries. Additionally is the driving factor this market.
  • in the US is the driving factor this market.
  • the two major funders of biomedical research is the driving factor this market.
  • including respiratory surgeries is the driving factor this market.
  • are the Federal Government is the driving factor this market.
  • primarily the National Institutes of Health (NIH) (with around 30% of the total funding) and pharmaceutical companies (with around 65% of the total funding). Hence is the driving factor this market.
  • these factors are enabling further activities in respiratory research is the driving factor this market.
  • thereby driving the growth of the global preclinical respiration and inhalation lab equipment market during the forecast period. is the driving factor this market.

The Preclinical Respiration and Inhalation Lab Equipment market vendors should focus on grabbing business opportunities from the Respiration equipment segment as it accounted for the largest market share in the base year.